Pharma Journalist -

AcelRx Pharmaceuticals announced the execution of a definitive merger agreement to acquire Tetraphase Pharmaceuticals, Inc. (Tetraphase) in a stock for stock deal at an exchange ratio…
Read More...

Regeneron Pharmaceuticals and Sanofi announced they have started a clinical program evaluating Kevzara (sarilumab) in patients hospitalized with severe COVID-19 infection. Kevzara is a…
Read More...

XORTX Therapeutics Inc. a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, with late stage clinical programs, announces that it…
Read More...

BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. announced the buildout of a brand new R&D lab. Situated in the Company's 6,100 sq. Ft.,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced an update from the Phase III JAVELIN Head and Neck 100 study…
Read More...

Thermo Fisher Scientific announced it has signed an agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to co-develop a companion…
Read More...

Eurofins announces that two of its clinical diagnostic testing laboratories in the United States now offer testing for evaluation of COVID-19. On 13 March 2020, Viracor Eurofins, one of…
Read More...

FUJIFILM Diosynth Biotechnologies (FDB), a world leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting its partners in the biopharmaceutical industry with…
Read More...

Tyligand Bioscience, Ltd. and Context Therapeutics LLC announced the signing of collaboration agreements for the manufacturing, registration and future commercialization of onapristone…
Read More...

AbCellera and Eli Lilly and Company announced they have entered into an agreement to co-develop antibody products for the treatment and prevention of COVID-19, the disease caused by the…
Read More...